Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of the intraocular pressure (IOP) lowering effect of one, two, or three iStent devices in eyes of subjects previously on two anti-glaucoma medications.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01517477
Study type Interventional
Source Glaukos Corporation
Contact
Status Completed
Phase N/A
Start date January 2012
Completion date October 18, 2019

See also
  Status Clinical Trial Phase
Completed NCT01085357 - Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery N/A
Completed NCT02434692 - Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) N/A
Completed NCT02700984 - A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial N/A
Recruiting NCT06016972 - Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients Phase 2
Terminated NCT01180062 - Safety Study of Latanoprost Slow Release Insert Phase 1
Terminated NCT03478293 - iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications N/A
Completed NCT01166659 - Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy N/A
Completed NCT01252849 - Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects N/A
Active, not recruiting NCT00902109 - Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients N/A